walnuts and almonds
Dietary SupplementThe subjects consumed 15g of walnuts and 15g of almonds/day for 8 weeks
NCT Number: NCT03211754
In this work, the investigators report the effects of consume of 15g walnuts and 15g almonds for 8 week on weight, waist and hip circumferences, body mass index, fat mass, serum LDL-cholesterol adiponectin, lipocalin-2 concentration and fatty acids profile.
Looking for future studies?
Notify Me30 year–50 year
All sexes
Interventional
Not applicable
The study consists of a diet-intervention in a single group under-free-living conditions. The diet was enriched with 15g of almonds and 15g of walnuts per day for eight weeks, supplied directly to the patient by the researcher. This amounts of walnuts and almonds contain polyunsaturated fatty acids of approximately 2.02g of omega 3 (alpha-linolenic acid) and 11.1g of omega 6 (linoleic acid) mostly. In a period of 14 months, the investigators recruited forty-eight sedentary subjects of 30 to 50 years old, and body mass index between 30 and 34.9 kg/m2, without evidence of chronic degenerative, infectious or neoplastic diseases, neither medication nor actually dietary treatment, and a physical level of exercise < 2 hours/week. All participants gave their written informed consent to participate in the study. The study was approved by the Institutional Ethics Committee of the Universidad de Guanajuato.
Collected data included the clinical-nutritional history, 24-hour recalls, and the International Physical Activity Questionnaire was applied to evaluate if subjects were sedentary. The dietary intake evaluation was estimated in kilocalories/day, the amount and type of macronutrients according to the database of United States Department of Agriculture and the National Institute of Public Health (Mexico). In order to evaluate adherence to the diet, volunteers were visited every two weeks to carry out three 24-hour recalls (two on weekdays and one on weekends). Positive Adherence to the diet plan was considered when the food consumption, walnuts and almonds were not modified more than ± 20% of the amount indicated by the researcher.
The investigators recorded the anthropometric measures, body composition, and measured serum glucose, lipid profile, insulin, lipocalin 2, high sensitivity C-reactive protein, adiponectin, and fatty acids profile, which were analyzed at the baseline and after dietary intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The subjects consumed 15g of walnuts and 15g of almonds/day for 8 weeks
Time frame: 8 weeks
fatty acids in percentage
Time frame: 8 weeks
Weight in kilograms
Time frame: 8 weeks
height in meters
Time frame: 8 weeks
waist circumference in centimeters
Time frame: 8 weeks
hip circumference in centimeters
Time frame: 8 weeks
fat mass in percentage
Time frame: 8 weeks
Weight and height will be combined to report BMI in kg/m2
Time frame: 8 weeks
Glucose in mg/dL
Time frame: 8 weeks
total Cholesterol in mg/dL
Time frame: 8 weeks
LDL-cholesterol in mg/dL
Time frame: 8 weeks
HDL-cholesterol in mg/dL
Time frame: 8 weeks
triglycerides in mg/dL
Time frame: 8 weeks
Lipocalin-2 in mg/mL
Time frame: 8 weeks
Insulin in pmol/L
Time frame: 8 weeks
High sensitivity C-reactive protein in mg/L
Time frame: 8 weeks
adiponectin in microg/mL
Universidad de Guanajuato
Other
Changes on Anthropometric Measures and Anti-inflammatory Markers by a PUFAs Enriched Diet in Obese Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details